PT  - JOURNAL ARTICLE
AU  - Gibertoni, Dino
AU  - Adja, Kadjo Yves Cedric
AU  - Golinelli, Davide
AU  - Reno, Chiara
AU  - Regazzi, Luca
AU  - Fantini, Maria Pia
TI  - Patterns of COVID-19 related excess mortality in the municipalities of Northern Italy
AID  - 10.1101/2020.05.11.20097964
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.11.20097964
4099  - http://medrxiv.org/content/early/2020/05/14/2020.05.11.20097964.short
4100  - http://medrxiv.org/content/early/2020/05/14/2020.05.11.20097964.full
AB  - The Coronavirus Disease 2019 (COVID-19) spatial distribution in Italy is inhomogeneous, because of its ways of spreading from the initial hotspots. The impact of COVID-19 on mortality has been described at the regional level, while less is known about mortality in demographic subgroups within municipalities.We aimed to describe the excess mortality (EM) due to COVID-19 in the three most affected Italian regions, by estimating EM in subgroups defined by gender and age classes within each municipality from February 23 to March 31, 2020.EM varied widely among municipalities even within the same region; it was similar between genders for the ≥75 age group, while in the other age groups it was higher in males. Thus, nearby municipalities may show a different mortality burden despite being under common regional health policies, possibly as a result of policies adopted both at the regional and at the municipality level.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data referred to are public data given by the Italian National Institute of Statistics. Supplementary data will be made available at request